Production (Stage)
Concentrix Corporation
CNXC
$58.62
-$0.96-1.61%
NASDAQ
05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
---|---|---|---|---|---|
Revenue | 2.42B | 2.37B | 2.45B | 2.39B | 2.38B |
Total Other Revenue | -- | -- | -- | -- | 596.44M |
Total Revenue | 2.42B | 2.37B | 2.45B | 2.39B | 2.38B |
Cost of Revenue | 1.57B | 1.52B | 1.58B | 1.52B | 1.52B |
Gross Profit | 848.15M | 855.90M | 870.60M | 864.19M | 857.57M |
SG&A Expenses | 573.95M | 667.44M | 215.11M | 674.31M | 560.43M |
Depreciation & Amortization | 109.16M | -- | 458.93M | -- | 115.97M |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 2.25B | 2.18B | 2.25B | 2.20B | 2.20B |
Operating Income | 165.04M | 188.46M | 196.56M | 189.88M | 181.17M |
Income Before Tax | 51.72M | 100.79M | 112.91M | 26.42M | 87.13M |
Income Tax Expenses | 9.63M | 30.54M | -2.74M | 9.79M | 20.29M |
Earnings from Continuing Operations | 42.09M | 70.26M | 115.65M | 16.63M | 66.83M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 42.09M | 70.26M | 115.65M | 16.63M | 66.83M |
EBIT | 165.04M | 188.46M | 196.56M | 189.88M | 181.17M |
EBITDA | 330.35M | 349.17M | 365.28M | 366.00M | 358.11M |
EPS Basic | 0.63 | 1.04 | 1.73 | 0.25 | 0.98 |
Normalized Basic EPS | 0.76 | 1.14 | 1.50 | 0.71 | 1.07 |
EPS Diluted | 0.63 | 1.04 | 1.73 | 0.25 | 0.98 |
Normalized Diluted EPS | 0.76 | 1.14 | 1.50 | 0.70 | 1.07 |
Average Basic Shares Outstanding | 63.36M | 64.04M | 64.32M | 64.66M | 65.27M |
Average Diluted Shares Outstanding | 63.41M | 64.07M | 64.35M | 64.75M | 65.33M |
Dividend Per Share | 0.33 | 0.33 | 0.33 | 0.30 | 0.30 |
Payout Ratio | 52.59% | 31.86% | 19.57% | 121.54% | 30.44% |